Adage Capital Management, L.P.

Entity
Company
Business address
200 Clarendon Street, 52 Nd Floor, 02116 Boston, MA
Phone
617-867-2800
State of incorporation
DE
Fiscal year end
December 31
Signature 13F
Phillip Gross - Managing Member of Reporting Partner
Signature Schedule 13D/G
Adage Capital Management, L.P. - By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Signature Ownership
/s/ Adage Capital Management, L.P.; By: its general partner Adage Capital Partners LLC; By its managing member Robert Atchinson
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Adage Capital Management, L.P. has filed 112 SEC EDGAR filings since 7/10/2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open Document Open Filing Sep 2, 2025
N-PX Open Document Open Filing Aug 29, 2025 Jun 30, 2025 028-23349
3 Open Document Open Filing Aug 19, 2025 Aug 18, 2025 001-39620
13F-NT Open Document Open Filing Aug 14, 2025 Jun 30, 2025 028-23349
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G Open Document Open Filing Aug 12, 2025
SCHEDULE 13G Open Document Open Filing Aug 12, 2025
SCHEDULE 13G Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13G/A Open Document Open Filing Aug 12, 2025
SCHEDULE 13D/A Open Document Open Filing Jun 20, 2025
13F-NT Open Document Open Filing May 15, 2025 Mar 31, 2025 028-23349
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
SCHEDULE 13G/A Open Document Open Filing May 12, 2025
4 Open Document Open Filing Feb 19, 2025 Feb 18, 2025 001-38360
3 Open Document Open Filing Feb 19, 2025 Feb 18, 2025 001-38360
13F-NT Open Document Open Filing Feb 14, 2025 Dec 31, 2024 028-23349
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SCHEDULE 13G Open Document Open Filing Feb 12, 2025
SC 13G Open Document Open Filing ZEO ENERGY CORP. Nov 19, 2024
13F-NT Open Document Open Filing Nov 14, 2024 Sep 30, 2024 028-23349
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing ANNEXON, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing SAVARA INC. Nov 12, 2024
SC 13G/A Open Document Open Filing CORBUS PHARMACEUTICALS HOLDINGS, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing WEREWOLF THERAPEUTICS, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing PERELLA WEINBERG PARTNERS Nov 12, 2024
SC 13G/A Open Document Open Filing AMALGAMATED FINANCIAL CORP. Nov 12, 2024
SC 13G/A Open Document Open Filing GUILD HOLDINGS COMPANY Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing REZOLUTE, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing PRAXIS PRECISION MEDICINES, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing CABALETTA BIO, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing VINCI PARTNERS INVESTMENTS LTD. Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G/A Open Document Open Filing Nov 12, 2024
SC 13G Open Document Open Filing TENAX THERAPEUTICS, INC. Nov 12, 2024
SC 13G Open Document Open Filing HERON THERAPEUTICS, INC. Nov 12, 2024
SC 13G Open Document Open Filing IMMUNIC, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing MOLECULAR TEMPLATES, INC. Nov 12, 2024
SC 13G Open Document Open Filing ALIGOS THERAPEUTICS, INC. Nov 12, 2024
SC 13G/A Open Document Open Filing KALVISTA PHARMACEUTICALS, INC. Nov 12, 2024
SC 13G Open Document Open Filing LEXEO THERAPEUTICS, INC. Nov 12, 2024
SC 13G Open Document Open Filing UROGEN PHARMA LTD. Nov 12, 2024
SC 13G/A Open Document Open Filing SOLID BIOSCIENCES INC. Nov 12, 2024
SC 13G Open Document Open Filing ENGENE HOLDINGS INC. Nov 12, 2024
SC 13D Open Document Open Filing GLYCOMIMETICS INC Nov 4, 2024
SC 13D/A Open Document Open Filing Oct 22, 2024
N-PX Open Document Open Filing Sep 3, 2024 Jun 30, 2024 028-23349
13F-NT Open Document Open Filing Aug 14, 2024 Jun 30, 2024 028-23349
SC 13G/A Open Document Open Filing Jun 3, 2024
13F-NT Open Document Open Filing May 15, 2024 Mar 31, 2024 028-23349
4 Open Document Open Filing May 8, 2024 May 7, 2024 001-15771
SC 13G/A Open Document Open Filing EYEPOINT PHARMACEUTICALS, INC. May 1, 2024
SC 13G Open Document Open Filing EYEPOINT PHARMACEUTICALS, INC. Apr 30, 2024
3 Open Document Open Filing Apr 22, 2024 Apr 18, 2024 000-51122
SC 13D Open Document Open Filing ARCA BIOPHARMA, INC. Apr 5, 2024
13F-NT Open Document Open Filing Feb 14, 2024 Dec 31, 2023 028-23349
13F-NT Open Document Open Filing Nov 14, 2023 Sep 30, 2023 028-23349
13F-NT Open Document Open Filing Aug 14, 2023 Jun 30, 2023 028-23349
3 Open Document Open Filing Jul 10, 2023 Jul 3, 2023 001-15771